Reversible male contraception by targeted inhibition of serine/threonine kinase 33.
Journal
Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511
Informations de publication
Date de publication:
24 May 2024
24 May 2024
Historique:
medline:
23
5
2024
pubmed:
23
5
2024
entrez:
23
5
2024
Statut:
ppublish
Résumé
Men or mice with homozygous serine/threonine kinase 33 (
Identifiants
pubmed: 38781365
doi: 10.1126/science.adl2688
doi:
Substances chimiques
Contraceptive Agents, Male
0
Protein Serine-Threonine Kinases
EC 2.7.11.1
Protein Kinase Inhibitors
0
Small Molecule Libraries
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
885-890Commentaires et corrections
Type : CommentIn